πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11440951

Therapeutic antibodies to Marburg virus

The Government of the United States, as represented by the Secretary of the Army Β· Granted Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11434272

Anti-human papillomavirus 16 E7 T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11419949

Adeno-associated virus variant capsids and methods of use thereof

4D MOLECULAR THERAPEUTICS INC. Β· Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11420976

Heterocyclic compounds as anti-viral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11406697

Methods and compositions for treating glioma and medulloblastoma brain tumors using the zi

Regents of the University of Minnesota Β· Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11407818

Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using th

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11406690

Adeno-associated virus factor VIII vectors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11400150

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11390861

CRISPR/cas-related methods and compositions for treating herpes simplex virus

Editas Medicine, Inc. Β· Granted Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11377450

Functionalized heterocycles as antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11376318

Methods of preparing anti-human papillomavirus antigen t cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11370828

Anti-coronavirus antibodies and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Svcs. Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11371024

Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11369622

Methods and compounds to inhibit enveloped virus release

Northwestern University Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11369675

Broadly protective inactivated influenza virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11369674

Treatment method utilizing chikungunya virus (CHIKV) virus-like particles (VLPS) comprisin

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11364308

Adeno-associated virus variant capsids and methods of use thereof

4D MOLECULAR THERAPEUTICS INC. Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11365230

Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof

IMMUNE DESIGN CORP. Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11364227

Sphingosine kinase 2 inhibitor for treating coronavirus infection

RedHill Biopharma Ltd. Β· Granted Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11358953

Functionalized peptides as antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11357839

Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, and their us

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11352363

Spiropyrrolidine derived antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11345700

Methods of preparing inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11344615

Nucleic acids encoding chimeric dengue/Zika viruses optimized for growth and stability in

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted